Register for tickets here.
Delivered in partnership with Newcastle University we are excited to invite you to our next Science of… an absolute Core-ker of an event, hosted via Zoom. With the UK government planning to ease restrictions on 19th July 2021 this event is a great opportunity to get to grips with issues around Covid-19 immunity.
Prof. Muzlifah Haniffa, Newcastle University will discuss research centred around differing immune responses in individuals with asymptomatic Covid-19 and those who have a more serious reaction to the virus. This is a unique study and is one of only a few to look at people who are asymptomatic. It was conducted within the Human Cell Atlas Initiative whose mission is to create a comprehensive reference map of all human cells as a basis for understanding human health, diagnosing, monitoring and treating disease.
Prof. Muzlifah Haniffa is a Wellcome Trust Senior Research fellow, Lister Institute research fellow and Consultant Dermatologist based at Newcastle University. She graduated from medical school in Cardiff, trained as a junior doctor in Cambridge and received her dermatology specialist training in Newcastle. She is a Fellow of the Academy of Medical Sciences (2020) and the recipient of the Academy of Medical Sciences Foulkes Foundation Medal (2019) and the European Federation of Immunological Societies ACTERIA Prize in Immunology and Allergology (2018). Muzlifah is a leading member of the Human Cell Atlas initiative and pioneered the application of single cell genomics to decode the developing human immune system, and the human skin in health and disease. She is involved in the UK Coronavirus Immunology Consortium (UK-CIC) as well as the COVID-19 arm of the Human Cell Atlas.
Dr Christopher Duncan, Newcastle University will explore his research into how the immune system responds to Covid-19 and why this is critical for understanding the unknowns of the virus, such as why some people become very sick and others do not, what constitutes effective immunity and how long that immunity might last.
Christopher is a Wellcome Trust funded Clinician Scientist and an Honorary Consultant in Infectious Diseases. He came to Newcastle as an Academic Clinical Lecturer in 2014 following his DPhil in viral immunology at the Sir William Dunn School of Pathology, University of Oxford. Upon completion of his clinical training in 2017 he was appointed to a Faculty Fellowship, and in 2018 was awarded a Wellcome Trust Clinical Career Development Fellowship to establish his research group. Building on a strong track record of discovery of monogenic disorders of innate antiviral immunity, his group employs cutting-edge disease models to better understand how the innate immune system governs clinical outcome of viral disease, with the aim of developing novel antiviral therapies. Recently he has been Principal Investigator on a number of high profile COVID-19 clinical trials, including the Oxford/Astra Zeneca Vaccine Trial, and is the Newcastle lead for the UK Coronavirus Immunology Consortium.
Toby Hyam, Managing Director of Creative Space Management will host the event.
Register for tickets here.
We are always on the look-out for new content for The Science of…, if you have an interesting piece of research, project, art or installation within the themes of future city challenges or digital tech please do email us on email@example.com .